Ana-Clara Bobadilla

Ana-Clara Bobadilla

Auto-generated profile, based on publicly available information

Ana-Clara Bobadilla

Department of Biomedical Sciences, Colorado State University, Fort Collins, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2019 in Frontiers in Behavioral Neuroscience
Verified
Journal Article
Open access
PDF file
BKBrittany N. Kuhn
Brittany N. Kuhn
PKPeter W. Kalivas
Peter W. Kalivas
ABAna-Clara Bobadilla
Ana-Clara Bobadilla
Drug addiction is a neuropsychiatric disorder with grave personal consequences that has an extraordinary global economic impact. Despite decades of research, the options available to treat addiction are often ineffective because our rudimentary understanding of drug-induced pathology in brain circuits and synaptic physiology inhibits the rational design of successful therapies. This understanding will arise first from animal models of addiction where experimentation at the level of circuits and molecular biology is possible. We will review the most common preclinical models of addictive behavior and discuss the advantages and disadvantages of each. This includes non-contingent models in which animals are passively exposed to rewarding substances, as well as widely used contingent models such as drug self-administration and relapse. For the latter, we elaborate on the different ways of mimicking craving and relapse, which include using acute stress, drug administration or exposure to cues and contexts previously paired with drug self-administration. We further describe paradigms where drug-taking is challenged by alternative rewards, such as appetitive foods or social interaction. In an attempt to better model the individual vulnerability to drug abuse that characterizes human addiction, the field has also established preclinical paradigms in which drug-induced behaviors are ranked by various criteria of drug use in the presence of negative consequences. Separation of more vulnerable animals according to these criteria, along with other innate predispositions including goal- or sign-tracking, sensation-seeking behavior or impulsivity, has established individual genetic susceptibilities to developing drug addiction and relapse vulnerability. We further examine current models of behavioral addictions such as gambling, a disorder included in the DSM-5, and exercise, mentioned in the DSM-5 but not included yet due to insufficient peer-reviewed evidence. Finally, after reviewing the face validity of the aforementioned models, we consider the most common standardized tests used by pharmaceutical companies to assess the addictive potential of a drug during clinical trials.

1 December 2016 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
JHJasper A. Heinsbroek
Jasper A. Heinsbroek
DNDaniela N. Neuhofer
Daniela N. Neuhofer
WGWilliam C. Griffin
William C. Griffin
GSGriffin S. Siegel
Griffin S. Siegel
ABAna-Clara Bobadilla
Ana-Clara Bobadilla
PKPeter W. Kalivas
Peter W. Kalivas
Distinct populations of D1- and D2-dopamine receptor-expressing medium spiny neurons (D1-/D2-MSNs) comprise the nucleus accumbens, and activity in D1-MSNs promotes, whereas activity in D2-MSNs inhibits, motivated behaviors. We used chemogenetics to extend D1-/D2-MSN cell specific regulation to cue-reinstated cocaine seeking in a mouse model of self-administration and relapse, and found that either increasing activity in D1-MSNs or decreasing activity in D2-MSNs augmented cue-induced reinstatement. Both D1- and D2-MSNs provide substantial GABAergic innervation to the ventral pallidum, and chemogenetic inhibition of ventral pallidal neurons blocked the augmented reinstatement elicited by chemogenetic regulation of either D1- or D2-MSNs. Because D1- and D2-MSNs innervate overlapping populations of ventral pallidal neurons, we next used optogenetics to examine whether changes in synaptic plasticity in D1- versus D2-MSN GABAergic synapses in the ventral pallidum could explain the differential regulation of VP activity. In mice trained to self-administer cocaine, GABAergic LTD was abolished in D2-, but not in D1-MSN synapses. A μ opioid receptor antagonist restored GABA currents in D2-, but not D1-MSN synapses of cocaine-trained mice, indicating that increased enkephalin tone on presynaptic μ opioid receptors was responsible for occluding the LTD. These results identify a behavioral function for D1-MSN innervation of the ventral pallidum, and suggest that losing LTDGABAin D2-MSN, but not D1-MSN input to ventral pallidum may promote cue-induced reinstatement of cocaine-seeking.SIGNIFICANCE STATEMENTMore than 90% of ventral striatum is composed of two cell types, those expressing dopamine D1 or D2 receptors, which exert opposing roles on motivated behavior. Both cell types send GABAergic projections to the ventral pallidum and were found to differentially promote cue-induced reinstatement of cocaine seeking via the ventral pallidum. Furthermore, after cocaine self-administration, synaptic plasticity was selectively lost in D2, but not D1 inputs to the ventral pallidum. The selective impairment in D2 afferents may promote the influence of D1 inputs to drive relapse to cocaine seeking.

1 September 2017 in Neuron
Verified
Journal Article
Closed access
MTMakoto Taniguchi
Makoto Taniguchi
MCMaria B. Carreira
Maria B. Carreira
YCYonatan A. Cooper
Yonatan A. Cooper
ABAna-Clara Bobadilla
Ana-Clara Bobadilla
JHJasper A. Heinsbroek
Jasper A. Heinsbroek
CCChristopher W. Cowan
Christopher W. Cowan

28 September 2020 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
ABAna-Clara Bobadilla
Ana-Clara Bobadilla
EDEric Dereschewitz
Eric Dereschewitz
LVLucio Vaccaro
Lucio Vaccaro
JHJasper A. Heinsbroek
Jasper A. Heinsbroek
MSMichael D. Scofield
Michael D. Scofield
PKPeter W. Kalivas
Peter W. Kalivas

1 February 2020 in Cell Reports
Verified
Journal Article
Open access
JHJasper A. Heinsbroek
Jasper A. Heinsbroek
ABAna-Clara Bobadilla
Ana-Clara Bobadilla
EDEric Dereschewitz
Eric Dereschewitz
AAAhlem Assali
Ahlem Assali
RCReda M. Chalhoub
Reda M. Chalhoub
PKPeter W. Kalivas
Peter W. Kalivas
Projections from the nucleus accumbens to the ventral pallidum (VP) regulate relapse in animal models of addiction. The VP contains GABAergic (VPGABA) and glutamatergic (VPGlu) neurons, and a subpopulation of GABAergic neurons co-express enkephalin (VPPenk). Rabies tracing reveals that VPGlu and VPPenk neurons receive preferential innervation from upstream D1- relative to D2-expressing accumbens neurons. Chemogenetic stimulation of VPGlu neurons inhibits, whereas stimulation of VPGABA and VPPenk neurons potentiates cocaine seeking in mice withdrawn from intravenous cocaine self-administration. Calcium imaging reveals cell type-specific activity patterns when animals learn to suppress drug seeking during extinction training versus engaging in cue-induced cocaine seeking. During cued seeking, VPGABA neurons increase their overall activity, and VPPenk neurons are selectively activated around nose pokes for cocaine. In contrast, VPGlu neurons increase their spike rate following extinction training. These data show that VP subpopulations differentially encode and regulate cocaine seeking, with VPPenk and VPGABA neurons facilitating and VPGlu neurons inhibiting cocaine seeking.

13 February 2021 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
Rusty W NallRusty W Nall
Rusty W Nall
JHJasper A. Heinsbroek
Jasper A. Heinsbroek
TNTodd B. Nentwig
Todd B. Nentwig
PKPeter W. Kalivas
Peter W. Kalivas
ABAna‐Clara Bobadilla
Ana‐Clara Bobadilla